Celltex Therapeutics specializes in the banking and therapeutic use of mesenchymal stem cells (MSCs), which are derived from a patient's own adipose (fat) tissue. The company employs a proprietary process to isolate, culture, and cryopreserve these stem cells, ensuring they maintain high levels of purity and potency. Their state-of-the-art laboratory in Houston, Texas, operates under strict FDA guidelines and Current Good Manufacturing Practices (cGMP), allowing for the production of billions of genetically stable MSCs. These cells have been utilized in over 10,000 therapies, addressing a variety of health issues, including chronic pain, autoimmune diseases, and recovery from injuries.

In addition to their banking services, Celltex is actively involved in clinical research, conducting multiple trials to evaluate the safety and efficacy of MSCs for various conditions, including severe COVID-19 symptoms, rheumatoid arthritis, and Alzheimer's disease. The company collaborates with certified physicians and institutions, such as Texas A&M University, to advance their research and ensure that their therapies are accessible to patients. By focusing on the therapeutic potential of a patient's own stem cells, Celltex aims to improve quality of life and provide innovative solutions in regenerative medicine.

United States

Celltex Therapeutics Corporation is a Houston, Texas-based biotechnology company focused on spearheading breakthroughs in regenerative medicine using adult, autologous Mesenchymal Stem Cells (MSCs).

Celltex Therapeutics

Company Details